TrialDiabetes, obesity & metabolism2022

Pharmacokinetic and pharmacodynamic equivalence of Biocon's biosimilar Insulin 70/30 with US-licensed HUMULIN® 70/30 formulation in healthy subjects: Results from the RHINE-3 (Recombinant Human INsulin Equivalence-3) study.

Leona Plum-Mörschel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.